AXA  Sells CABB to Another Private Equity Firm

Private equity firm Bridgepoint (Frankfurt) has agreed to buy fine and specialty chemical maker CABB (Sulzbach/Taunus, Germany) from AXA Private Equity (Paris). Bridgepoint has agreed to pay €340 million ($474 million) sources close to the deal say.  Bridgepoint says CABB is the global market leader in monochloroacetic acid (MCAA), which is used in the food industry, herbicides, and personal care products. AkzoNobel claims it is the world’s largest producer of MCAA. CABB is also a leading custom manufacturer for global agrochemical, chemical...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers